Genome-informed targeted therapy for osteosarcoma

LC Sayles, MR Breese, AL Koehne, SG Leung, AG Lee… - Cancer discovery, 2019 - AACR
Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially
unchanged for more than 30 years. Osteosarcoma is characterized by widespread and …
被引用次数：314 相关文章

Genome-Informed Targeted Therapy for Osteosarcoma

LC Sayles, K Straessler, FK Hazard, SL Spunt… - Cancer, 2019 - hero.epa.gov
Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially
unchanged for more than 30 years. Osteosarcoma is characterized by widespread and …

Genome-Informed Targeted Therapy for Osteosarcoma

LC Sayles, MR Breese, AL Koehne, SG Leung… - Cancer …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title/>< jats: p> Osteosarcoma is a
highly aggressive cancer for which treatment has remained essentially unchanged for more …

Genome-Informed Targeted Therapy for Osteosarcoma.

LC Sayles, MR Breese, AL Koehne, SG Leung… - Cancer …, 2018 - europepmc.org
Osteosarcoma (OS) is a highly aggressive cancer for which treatment has remained
essentially unchanged for over 30 years. OS is characterized by widespread and recurrent …

Genome-Informed Targeted Therapy for Osteosarcoma

LC Sayles, MR Breese, AL Koehne… - Cancer …, 2019 - pubmed.ncbi.nlm.nih.gov
Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially
unchanged for more than 30 years. Osteosarcoma is characterized by widespread and …

Genome-informed targeted therapy for osteosarcoma

LC Sayles, MR Breese, AL Koehne… - Cancer …, 2019 - utsouthwestern.elsevierpure.com
Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially
unchanged for more than 30 years. Osteosarcoma is characterized by widespread and …
[HTML] nih.gov

[HTML][HTML] Genome-Informed Targeted Therapy for Osteosarcoma

LC Sayles, MR Breese, AL Koehne, SG Leung… - Cancer …, 2019 - ncbi.nlm.nih.gov
Osteosarcoma (OS) is a highly aggressive cancer for which treatment has remained
essentially unchanged for over 30 years. OS is characterized by widespread and recurrent …

Genome-Informed Targeted Therapy for Osteosarcoma

LC Sayles, MR Breese, AL Koehne, SG Leung… - Cancer …, 2019 - escholarship.org
Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially
unchanged for more than 30 years. Osteosarcoma is characterized by widespread and …